Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119320976 | 11932097 | 6 | F | 20151226 | 20160802 | 20160120 | 20160803 | EXP | US-ELI_LILLY_AND_COMPANY-US201601004737 | ELI LILLY AND CO | 72.55 | YR | M | Y | 96.96000 | KG | 20160803 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119320976 | 11932097 | 1 | PS | ADCIRCA | TADALAFIL | 1 | Unknown | 1 DF, UNKNOWN | U | U | 21368 | 1 | DF | ||||||
| 119320976 | 11932097 | 2 | SS | LETAIRIS | AMBRISENTAN | 1 | Unknown | 5 MG, QD | 1413180A | 0 | 5 | MG | TABLET | QD | |||||
| 119320976 | 11932097 | 3 | SS | TYVASO | TREPROSTINIL | 1 | Respiratory (inhalation) | 3 DF, QID | U | 2100705 | 0 | 3 | DF | QID | |||||
| 119320976 | 11932097 | 4 | SS | TYVASO | TREPROSTINIL | 1 | Respiratory (inhalation) | 12 DF, QID | U | 0 | 12 | DF | QID | ||||||
| 119320976 | 11932097 | 5 | SS | REMODULIN | TREPROSTINIL | 1 | Subcutaneous | 2 DF, OTHER CONTINUOUS | U | U | 926618 | 0 | 2 | DF | |||||
| 119320976 | 11932097 | 6 | SS | LASIX | FUROSEMIDE | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119320976 | 11932097 | 1 | Product used for unknown indication |
| 119320976 | 11932097 | 2 | Product used for unknown indication |
| 119320976 | 11932097 | 3 | Pulmonary arterial hypertension |
| 119320976 | 11932097 | 5 | Pulmonary arterial hypertension |
| 119320976 | 11932097 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119320976 | 11932097 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119320976 | 11932097 | Cough | |
| 119320976 | 11932097 | Infusion site pain | |
| 119320976 | 11932097 | Rash | |
| 119320976 | 11932097 | Throat tightness |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119320976 | 11932097 | 2 | 20150710 | 0 | ||
| 119320976 | 11932097 | 3 | 20150709 | 0 | ||
| 119320976 | 11932097 | 4 | 20150709 | 0 | ||
| 119320976 | 11932097 | 5 | 20160224 | 0 | ||
| 119320976 | 11932097 | 6 | 201512 | 0 |